Methotrexate is a high-risk drug, i.e. serious patient harm can occur as a result of errors involving incorrect frequency (daily rather once weekly), incorrect strength tablets, incorrect strength tablets, or from an adverse drug reaction. Care must be taken with methotrexate use at all stages of medication use, including at transitions of care. Click here to view IMSN’s Safety Alert on the Use of Once Weekly Oral Methotrexate
Recent Posts
- Lithium-Prescribing & Monitoring (Best Practice Guidelines and Patient Information) 22 July 2025
- Medication Safety Bulletins & other published material 2 July 2025
- World Parkinson’s Day – 11th April 2025 2 April 2025
- Ground-breaking All-Island Medication Safety Conference to Take Place Amidst Rising Healthcare Challenges 29 November 2024
- Parkinson’s disease: Reducing harm from medications (Safety Alerts) 11 November 2024
Trackbacks/Pingbacks